Transaction #24006 · Form 4 · 0001231919-25-000652
Kalaris Therapeutics, Inc. · Stock award · Common Stock
Kalaris Therapeutics, Inc. · Transacted December 22, 2025 · Filed December 22, 2025
What does this filing report?
An SEC Form 4 filing for Kalaris Therapeutics, Inc. records a stock award involving Common Stock on December 22, 2025. The reported quantity was 1,500,000. The filing date is December 22, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Kalaris Therapeutics, Inc.
- Company CIK
- 0001754068
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 1,500,000
- Reported price
- 10
- Reference value
- 15,000,000
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 1,500,000
- Ownership description
- By Samsara Opportunity Fund, L.P.
- SEC acceptance time
- Dec 22, 2025, 4:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- AKKARAJU SRINIVAS ↗
Director · 10% owner
CIK 0001253170
- Samsara Opportunity Fund, L.P. ↗
10% owner
CIK 0002086193
- Samsara Opportunity Fund GP, LLC ↗
10% owner
CIK 0002086456
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Samsara Opportunity GP and Dr. Akkaraju have voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of his or its respective pecuniary interest therein.
- F2
- Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.